Skip to main content

Brian Gowen

Profile Picture

Animal, Dairy and Veterinary Sciences

Virology

Research Professor

Educational Background

PhD, Biomedical Science, University of South Carolina, School of Medicine, 2000
BS, Microbiology, Colorado State University, 1993


Biography

Dr. Gowen specializes in pre-clinical development of antiviral therapies for the treatment of arenaviral and bunyaviral hemorrhagic fever agents, innate immunity to viral infections, modeling viral diseases, and virus-host cell interactions.


Research Interests

The Gowen laboratory is interested in understanding the pathogenesis of arenaviral and bunyaviral hemorrhagic fever viruses, and the development of effective countermeasures to prevent and treat the diseases they cause. The viruses studied include various new world arenaviruses including Junin, Pichinde, and Tacaribe, the Rift Valley fever, Heartland and severe fever with thrombocytopenia syndrome, as well as hantaviruses.


Contact Information

Go toOffice Location: VSB 309
DialPhone: 435-797-3112
SendEmail: brian.gowen@usu.edu

Awards

Distinguished Alumni Doctorate Award, 2014

University of South Carolina School of Medicine

William Prusoff Young Investigator Award, 2011

International Society for Antiviral Research

College of Agriculture Faculty Researcher of the Year, 2010

Utah State University College of Agriculture

Intramural Research Training Award, 2000

All-American Scholar Collegiate Award, 1994

National Collegiate Medical Professions Award, 1994

Phi Beta Kappa, 1994


    Publications - Books & Book Chapters

      * Has not been peer reviewed

      Publications - Fact Sheets

        * Has not been peer reviewed

        Publications - Curriculum

          * Has not been peer reviewed

          Publications - Journal Articles

            Academic Journal

          • Gowen, B., Westover, J.B, Miao, J., Van Wettere, A., Rigas, J., Hickerson, B.T, Jung, K.H, Li, R., Conrad, B.L, Nielson, S., Furuta, Y., Wang, Z., (2016). Modeling severe fever with thrombocytopenia syndrome virus infection in golden Syrian hamsters: Importance of STAT2 in preventing disease and effective treatment with favipiravir. Journal of Virology
          • Westover, J.B, Sefing, E.J, Bailey, K.W, Van Wettere, A., Jung, K.H, Dagley, A., Wandersee, L., Downs, B., Smee, D., Furuta, Y., Bray, M., Gowen, B., (2016). Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses. Antiviral Research
          • Safronetz, D., Rosenke, K., Westover, J.B, Martellaro, C., Okumura, A., Furuta, Y., Geisbert, J., Saturday, G., Komeno, T., Geisbert, T.W, Feldmann, H., Gowen, B., (2015). The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset. Sci Rep, 5, 14775.
          • Gowen, B., Westover, J.B, Sefing, E.J, Bailey, K.W, Nishiyama, S., Wandersee, L., Scharton, D., Jung, K.H, Ikegami, T., (2015). MP-12 virus containing the clone 13 deletion in the NSs gene prevents lethal disease when administered after Rift Valley fever virus infection in hamsters. Front Microbiol, 6, 651.
          • Falcinelli, S., Gowen, B., Trost, B., Napper, S., Kusalik, A., Johnson, R.F, Safronetz, D., Prescott, J., Kindrachuck, J., (2015). Characterization of the host response to Pichinde virus infection in the Syrian golden hamster by species-specific kinome analysis. Mol Cell Proteomics, 14, 646-57.
          • Scharton, D., Van Wettere, A., Bailey, K.W, Vest, Z., Westover, J.B, Siddharthan, V., Gowen, B., (2015). Rift Valley Fever Virus Infection in Golden Syrian Hamsters. PLoS ONE, 10:1, e0116722.
          • Smith, D.R, Holbrook, M.R, Gowen, B., (2014). Animal Models of Viral Hemorrhagic Fever. Antiviral Research, 112C, 59-79.
          • Scharton, D., Bailey, K.W, Vest, Z., Westover, J.B, Kumaki, Y., Van Wettere, A., Furuta, Y., Gowen, B., (2014). Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment. Antiviral research, 104, 84–92.
          • Dagley, A., Ennis, J., Turner, J.D, Rood, K., Van Wettere, A., Gowen, B., Julander, J., (2014). Protection against Chikungunya virus induced arthralgia following prophylactic treatment with adenovirus vectored interferon (mDEF201). Antiviral Research, 108, 1-9. doi: 10.1016/j.antiviral.2014.05.004
          • Scharton, D., Bailey, K.W, Vest, Z., Westover, J.B, Kumaki, Y., Skirpstunas, R., Furuta, Y., Gowen, B., (2014). Post-exposure vaccination with MP-12 lacking NSs protects mice against lethal Rift Valley fever virus challenge. Antiviral Research, 104, 84-92.
          • Gowen, B., Ennis, J., Bailey, K., Vest, Z., Scharton, D., Sefing, E.J, Turner, J., (2014). Single-dose intranasal treatment with DEF201 (adenovirus vectored consensus interferon) prevents lethal disease due to Rift Valley fever virus challenge. Viruses, 108, 1-9.
          • Gowen, B., Jung, K., Sefing, E.J, Wong, M., Westover, J.B, Smee, D., (2014). Activity of a phenolic dibenzylsulfide against New World arenavirus infections. Antiviral Chemistry & Chemotherapy, 23:4, 151-159.
          • Gowen, B., Juelich, T.L, Sefing, E.J, Brasel, T., Smith, J.K, Zhang, L., Tigabu, B., Hill, T.E, Yun, T., Pietzsch, C., Furuta, Y., Freiberg, A.N, (2013). Favipiravir (T-705) Inhibits Junn Virus Infection and Reduces Mortality in a Guinea Pig Model of Argentine Hemorrhagic Fever. PLoS Negl. Trop. Dis., 7:12, e2614.
          • Furuta, Y., Gowen, B., Takahashi, K., Shiraki, K., Smee, D., Barnard, D., (2013). Favipiravir (T-705), a novel viral RNA polymerase inhibitor. Antiviral Research, 100:2, 446-454.
          • Safronetz, D., Falzarano, D., Scott, D.P, Furuta, Y., Feldmann, H., Gowen, B., (2013). Antiviral efficacy of favipiravir against two prominent etiological agents of hantavirus pulmonary syndrome. Antimocrobial Agents & Chemotherapy, 57:10, 4673-80.
          • Sefing, E.J, Wong, M., Larson, D.P, Hurst, B.L, Van Wettere, A., Schneller, S.W, Gowen, B., (2013). Vascular leak ensues a vigorous proinflammatory cytokine response to Tacaribe arenavirus infection in AG129 mice. Virology Journal, 10, 221.
          • Gowen, B., Bailey, K.W, Scharton, D., Vest, Z., Westover, J.B, Skirpstunas, R., Ikegami, T., (2013). Post-exposure vaccination with MP-12 lacking NSs protects mice against lethal Rift Valley fever virus challenge. Antiviral Research, 98:2, 135-143.
          • Gowen, B., Ennis, J., Sefing, E.J, Wong, M., Jung, K., Turner, J., (2012). Extended protection against phlebovirus infection conferred by recombinant adenovirus expressing consensus interferon (DEF201). Antimocrobial Agents & Chemotherapy, 56:8, 4168-74.
          • Gowen, B., Bray, M., (2011). Progress in the experimental therapy of severe arenaviral infections. Future Microbiol, 6, 1429-41.
          • Gowen, B., Ennis, J., Andrew, R., Sefing, E.J, Wong, M., Turner, J., (2011). Use of recombinant adenovirus vectored consensus IFN-α to avert severe arenavirus infection. PLoS One, 6:10, e26072.
          • Mendenhall, M., Russell, A., Smee, D., Hall, J.O, Skirpstunas, R., Furuta, Y., Gowen, B., (2011). Effective oral favipiravir (T-705) therapy initiated after the onset of clinical disease in a model of arenavirus hemorrhagic Fever. PLoS Negl. Trop. Dis., 5:10, e1342.
          • Buys, K.K, Jung, K., Smee, D., Furuta, Y., Gowen, B., (2011). Maporal virus as a surrogate for pathogenic New World hantaviruses and its inhibition by favipiravir. Antivir. Chem. Chemother., 21:5, 193-200.
          • Mendenhall, M., Russell, A., Juelich, T., Messina, E.L, Smee, D., Freiberg, A.N, Holbrook, M.R, Furuta, Y., de la Torre, J.C, Nunberg, J.H, Gowen, B., (2011). T-705 (Favipiravir) inhibition of arenavirus replication in cell culture. Antimicrob. Agents Chemother., 55:2, 782-787.
          • Gowen, B., Julander, J., London, N.R, Wong, M.H, Larson, D., Morrey, J.D, Li, D.Y, Bray, M., (2010). Assessing changes in vascular permeability in a hamster model of viral hemorrhagic fever. Virol. J., 7, 240.
          • Gowen, B., Julander, J., London, N.R, Wong, M.H, Larson, D., Morrey, J.D, Li, D.Y, Bray, M., (2010). Assessing changes in vascular permeability in a hamster model of viral hemorrhagic fever. Virol. J., 7:240, 1-13.
          • Gowen, B., Wong, M.H, Larson, D., Ye, W., Jung, K.H, Sefing, E.J, Skirpstunas, R., Smee, D., Morrey, J.D, Schneller, S.W, (2010). Development of a new Tacaribe arenavirus infection model and its use to explore antiviral activity of a novel aristeromycin analog. PLoS ONE, 5:9, pii: e12760.
          • Gowen, B., Wong, M., Jung, K., Smee, D., Morrey, J.D, Furuta, Y., (2010). Efficacy of favipiravir (T-705) and T-1106 pyrazine derivatives in phlebovirus disease models. Antiviral Res., 86:2, 121-127.
          • Mendenhall, M., Wong, M.H, Skirpstunas, R., Morrey, J.D, Gowen, B., (2009). Punta Toro virus (Bunyaviridae, Phlebovirus) infection in mice: strain differences in pathogenesis and host interferon response.. Virology, 395, 143-51.
          • Duran, N., Gowen, B., Costa, F.T, Justo, G.Z, Brocchi, M., Nunes, O.S, Nunes, I.S, (2009). A biotechnological product and its potential as a new immunomodulator for treatment of animal phlebovirus infection: Punta Toro virus.. Antiviral Res, 83:2, 143-7.
          • Furuta, Y., Takahashi, K., Shiraki, K., Sakamoto, K., Smee, D., Barnard, D., Gowen, B., Julander, J., Morrey, J.D, (2009). T-705 (favipiravir) and related compounds: novel broad-spectrum inhibitors of RNA viral infections. Antiviral Res, 82:3, 95-102.
          • Gowen, B., Fairman, J., Dow, S.W, Troyer , R., Wong, M.H, Jung, K.H, Melby, P.C, Morrey, J.D, (2009). Prophylaxis with cationic liposome-DNA complexes protects hamsters from phleboviral disease: Importance of liposomal delivery and CpG motifs.. Antiviral Res, 81:1, 37-46.
          • Smee, D., Gowen, B., Wandersee, M.K, Wong, M., Skirpstunas, R., Baldwin, T.J, Hoopes, J.D, Sidwell, R.W, (2008). Differential pathogenesis of cowpox virus intranasal infections in mice induced by low and high inoculum volumes and effects of cidofovir treatment. International Journal of Antimicrobial Agents, 31, 352-359.
          • Gowen, B., Smee, D., Wong, M., Hall, J.O, Jung, K., Bailey, K.W, Stevens, J.R, Furuta, Y., Morrey, J.D, (2008). Treatment of late stage disease in a model of arenaviral hemorrhagic fever: T-705 efficacy and reduced toxicity suggests an alternative to ribavirin. PLoS ONE, 3:11, e3725.
          • Gowen, B., Judge, J.W, Wong, M.H, Jung, K.H, Aylsworth, C.F, Melby, P.C, Rosenberg, B., Morrey, J.D, (2008). Immunoprophylaxis of Punta Toro virus (Phlebovirus, Bunyaviridae) infection in hamsters with recombinant Eimeria profilin-like antigen.. Int. Immunopharmacol., 8, 1089-94.
          • Subramanian, G.M, Moore, P.A, Gowen, B., Olsen, A.L, Barnard, D., Paragas, J., Hogan, R.J, Sidwell, R.W, (2008). Potent in vitro activity of the albumin fusion type 1 interferons (albumin-interferon-alpha and albumin-interferon-beta) against RNA viral agents of bioterrorism and the severe acute respiratory syndrome (SARS) virus. Chemotherapy, 54:3, 176-180.
          • Holbrook, M.R, Gowen, B., (2008). Animal models of highly pathogenic RNA viral infections: Encephalitis viruses. Antiviral Res., 78, 69-78.
          • Gowen, B., Holbrook, M.R, (2008). Animal models of highly pathogenic RNA viral infections: Hemorrhagic fever viruses. Antiviral Res., 78, 79-90.
          • Smee, D., Gowen, B., Wandersee, M.K, Wong, M., Skirpstunas, R.T, Baldwin, T.J, Hoopes, J.D, Sidwell, R.W, (2008). Differential pathogenesis of cowpox virus intranasal infections in mice induced by low and high inoculum volumes, and effects of cidofovir treatment. Int. J. Antimicrob. Agents, 31:4, 352-359.
          • Gowen, B., Wong, M.H, Jung, K.H, Blatt, L.M, Sidwell, R.W, (2008). Prophylactic and therapeutic intervention of Punta Toro virus (Phlebovirus, Bunyaviridae) infection in hamsters with Interferon Alfacon-1.. Antiviral Res., 77, 215-24.
          • Ma, X., Liu, Y., Gowen, B., Graviss, E.A, Clark, A.G, Musser, J.M, (2007). Full-exon sequencing reveals toll-like receptor variants contribute to human susceptibility to tuberculosis disease.. PLoS ONE, 2, e1318.
          • Selvam, P., Vijayalakshimi, P., Smee, D., Gowen, B., Julander, J., Day, C.W, Barnard, D., (2007). Novel 3-sulphonamido-quinazolin-4(3H)-one derivatives: microwave-assisted synthesis and evaluation of antiviral activities against respiratory and biodefense viruses.. Antiviral Chemistry and Chemotherapy/International Medical Press, 18:5, 301-5.
          • Gowen, B., Wong, M.H, Jung, K.H, Sanders, A.B, Mendenhall, M., Bailey, K.W, Furuta, Y., Sidwell, R.W, (2007). In vitro and in vivo activity of T-705 against arenavirus and bunyavirus infections. Antimicrob. Agents Chemother., 51, 3168-76.
          • Selvam, P., Vigayalakshimi, B., Smee, D.F, Gowen, B., Julander, J.G, Day, C.W, Barnard, D.L, (2007). Novel-3-sulphonamido-quinazolin-4(3H)-one derivatives: microwave-assisted synthesis and evaluation of anti-viral activities against respiratory and biodefense viruses. Antivir. Chem. Chemother., 18, 301-5.
          • Gowen, B., Wong, M.H, Jung, K.H, Mitchell, W.M, Sanders, A.B, Alexopoulou, L., Flavell, R.A, Sidwell, R.W, (2007). TLR3 is essential for the induction of protective immunity against Punta Toro virus infection by the double-stranded RNA (dsRNA), poly(I:C12U), but not poly(I:C): Differential recognition of synthetic dsRNA molecules. J. Immunol., 178, 5200-8.
          • Gowen, B., Hoopes, J.D, Wong, M.H, Jung, K.H, Isakson, K.C, Alexopoulou, L., Flavell, R.A, Sidwell, R.W, (2006). TLR3 deletion limits mortality and disease severity due to phlebovirus infection. J. Immunol., 177, 6301-7.
          • Gowen, B., Smee, D.F, Wong, M.H, Pace, A.M, Jung, K.H, Bailey, K.W, Blatt, L.M, Sidwell, R.W, (2006). Combinatorial ribavirin and interferon alfacon-1 therapy of acute arenaviral disease in hamsters. Antivir. Chem. Chemother., 17, 175-83.
          • Gowen, B., Smee, D.F, Wong, M.H, Judge, J.W, Jung, K.H, Bailey, K.W, Pace, A.M, Rosenberg, B., Sidwell, R.W, (2006). Recombinant Eimeria protozoan protein elicits resistance to acute phlebovirus infection in mice but not hamsters. Antimicrob. Agents Chemother., 50, 2023-9.
          • Gowen, B., Fairman, J., Smee, D.F, Wong, M.H, Jung, K.H, Pace, A.M, Heiner, M.L, Bailey, K.W, Dow, S.W, Sidwell, R.W, (2006). Protective immunity against acute phleboviral infection elicited through immunostimulatory cationic liposome-DNA complexes. Antiviral Res., 69, 165-72.
          • Gowen, B., Barnard, D.L, Smee, D.F, Wong, M.H, Pace, A.M, Jung, K.H, Winslow, S.G, Bailey, K.W, Blatt, L.M, Sidwell, R.W, (2005). Interferon alfacon-1 protects hamsters from lethal Pichinde virus infection. Antimicrob. Agents Chemother., 49, 2378-86.
          • Sebbane, F., Gardner, D., Long, D., Gowen, B., Hinnebusch, B.J, (2005). Kinetics of disease progression and host response in a rat model of bubonic plague. Am. J. Pathol., 166, 1427-39.
          • Graham, M.R, Virtaneva, K., Porcella, S.F, Barry, W.T, Gowen, B., Johnson, C.A, Wright, F.A, Musser, J.M, (2005). Group A Streptococcus transcriptome dynamics during growth in human blood reveals bacterial adaptive and survival strategies. Am. J. Pathol., 166, 455-65.
          • Rebeil, R., Ernst, R.K, Gowen, B., Miller, S.I, Hinnebusch, B.J, (2004). Variation in lipid A structure in the pathogenic yersiniae. Mol. Microbiol., 52, 1363-73.
          • Hoe, N.P, Ireland, R.M, Deleo, F.R, Gowen, B., Dorward, D.W, Voyich, J.M, Liu, M., Burns, Jr., E.H, Culnan, D.M, Bretscher, A., Musser, J.M, (2002). Insight into the molecular basis of pathogen abundance: group A Streptococcus inhibitor of complement inhibits bacterial adherence and internalization into human cells. Proc. Nat. Acad. Sci. USA, 99, 7646-51.
          • Gowen, B., Borg, T.K, Ghaffar, A., Mayer, E.P, (2001). The collagenous domain of class A scavenger receptors is involved in macrophage adhesion to collagens. J. Leukoc. Biol., 69, 575-82.
          • Gowen, B., Borg, T.K, Ghaffer, A., Mayer, E.P, (2000). Selective adhesion of macrophages to denatured forms of type I collagen is mediated by scavenger receptors. Matrix Biol., 19, 61-71.
          • Professional Journal

          • Gowen, B., Sefing, E.J, Westover, J.B, Smee, D., Hagloch, J.H, Furuta, Y., Hall, J.O, (2015). Alterations in favipiravir (T-705) pharmacokinetics and biodistribution in a hamster model of viral hemorrhagic fever. Antiviral Res , 121, 132–137.

          * Has not been peer reviewed

          Publications - Literary Journal

            * Has not been peer reviewed

            Publications - MultiMedia

              * Has not been peer reviewed

              Publications - Technical Reports

                Research Reports

              • Morrey, J.D, Barnard, D., Smee, D., Gowen, B., (2009). Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
              • Smee, D., Barnard, D., Morrey, J.D, Gowen, B., Julander, J., (2009). Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
              • Morrey, J.D, Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2009). Semi-Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
              • Smee, D., Barnard, D., Morrey, J.D, Gowen, B., Julander, J., (2009). Semi-Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
              • Morrey, J.D, Barnard, D., Smee, D., Gowen, B., (2008). Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
              • Morrey, J.D, Barnard, D., Smee, D., Gowen, B., (2008). Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
              • Smee, D., Barnard, D., Morrey, J.D, Gowen, B., Julander, J., (2008). Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
              • Morrey, J.D, Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2008). Semi-Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
              • Smee, D., Barnard, D., Morrey, J.D, Gowen, B., Julander, J., (2008). Semi-Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
              • Morrey, J.D, Barnard, D., Smee, D., Gowen, B., (2007). Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
              • Smee, D., Barnard, D., Morrey, J.D, Gowen, B., Julander, J., (2007). Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
              • Morrey, J.D, Barnard, D., Smee, D., Gowen, B., (2007). Semi-Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
              • Smee, D., Barnard, D., Morrey, J.D, Gowen, B., Julander, J., (2007). Semi-Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
              • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2006). Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
              • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., Julander, J., (2006). Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
              • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., Julander, J., (2006). Semi Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
              • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2006). Semi-Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
              • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2005). Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
              • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2005). Semi Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
              • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2005). Semi-Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
              • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2004). Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
              • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2004). Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
              • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2004). Semi Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
              • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2004). Semi-Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
              • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2003). Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
              • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2003). Semi Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
              • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2002). Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
              • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2002). Semi Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
              • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2001). Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
              • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2001). Semi Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
              • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2000). Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
              • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2000). Semi Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
              • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (1999). Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
              • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (1999). Semi Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .

              * Has not been peer reviewed

              Publications - Translations & Transcripts

                Publications - Other

                  * Has not been peer reviewed

                  Scheduled Teaching

                  ADVS 7535 - Veterinary Virology, Fall 2017

                  VM 7535 - Veterinary Virology, Fall 2017

                  ADVS, VM 7535 - Veterinary Virology, Fall 2016

                  ADVS, VM 7535 - Veterinary Virology, Fall 2015

                  VM 7535 - Veterinary Virology, Fall 2014

                  VM 7535 - Veterinary Virology, Fall 2013


                  Graduate Students Mentored

                  Dionna Scharton, Animal, Dairy and Veterinary Sciences 2014
                  Eric Sefing, Animal, Dairy and Veterinary Sciences 2012
                  Kristin Kaufman, Animal, Dairy and Veterinary Sciences 2010
                  Michelle Mendenhall, Animal, Dairy and Veterinary Sciences 2009